Cephalon And Barr Reach Patent Settlements For Provigil, Actiq

Barr could gain up to two months of exclusivity for its Actiq generic.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet